Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2009

01-09-2009 | Original Article

Endoscopic Findings and Clinicopathologic Characteristics of Ischemic Colitis: A Report of 85 Cases

Authors: Xiaoping Zou, Jun Cao, Yulin Yao, Wenjia Liu, Longdian Chen

Published in: Digestive Diseases and Sciences | Issue 9/2009

Login to get access

Abstract

Ischemic colitis is the most common type of intestinal ischemia and has a clinical spectrum of injury that ranges from mild and transient ischemia to acute fulminant colitis. The aim of this study was to explore endoscopic findings and clinicopathologic characteristics of ischemic colitis and be accurate enough to avoid missed diagnosis or misdiagnosis. A retrospective analysis was undertaken of endoscopy findings and clinicopathologic characteristics of 85 cases of ischemic colitis from March 2005 to April 2008 in the endoscopy center of our hospital. All cases underwent colonoscopy with biopsy within 2 weeks of the onset of symptoms, and all specimens with forceps were stained with hematoxylin–eosin and observed under light microscopy. Of the 85 cases of ischemic colitis (24 men and 61 women, average age 61.36 ± 14.49 years old, range 29–84), 71 were over 50 years of age. These cases were associated with the basal diseases such as hypertension, cardiovascular disorders, diabetes, and hematological diseases as well as a history of abdominal operation. The clinical features usually presented with sudden onset of abdominal pain, diarrhea, and hematochezia. Ischemic lesions were located mainly in the left colon with segmental form (only descending colon affected 16%, only splenic flexure 14%, and only sigmoid colon 23%). The 85 patients consisted of the non-gangrenous type (82), which were composed of reversible IC (76) and chronic IC (6), and the gangrenous type (3). Endoscopic appearance of the transient ischemic colitis consisted of petechial hemorrhages, edematous and fragile mucosa, segmental erythema, scattered erosion, longitudinal ulcerations, and sharply defined segment of involvement. Ischemic colitis of stricture was characterized by full-thickness mucosa, lumens stricture, and diseased haustrations. The mucosa of gangrenous colitis with cyanotic and pseudopolyps was endoscopically observed as well. Clinicopathologic characteristics showed mucosal inflammation accompanied by erosion, granulation tissue hyperplasia and gland atrophy, lamina propria hemorrhage, and macrophages with hemosiderin pigmentation in submucosa in particular. Although endoscopy findings and clinicopathologic characteristics of ischemic colitis are nonspecific, colonoscopy with biopsy plays a vital role in the early diagnosis of ischemic colitis.
Literature
2.
go back to reference Newman JR, Cooper MA. Lower gastrointestinal bleeding and ischemic colitis. Can J Gastroenterol. 2002;16:597–600.PubMed Newman JR, Cooper MA. Lower gastrointestinal bleeding and ischemic colitis. Can J Gastroenterol. 2002;16:597–600.PubMed
7.
go back to reference Boley SJ, Schwartz S, Lash J, et al. Reversible vascular occlusion of the colon. Surg Crynecol Obstet. 1963;116:53–60. Boley SJ, Schwartz S, Lash J, et al. Reversible vascular occlusion of the colon. Surg Crynecol Obstet. 1963;116:53–60.
9.
go back to reference Chang L, Kahler KH, Sarawate C, et al. Assessment of potential risk factors associated with ischaemic colitis. Neurogastroenterol Motil. 2008;20:36–42.PubMed Chang L, Kahler KH, Sarawate C, et al. Assessment of potential risk factors associated with ischaemic colitis. Neurogastroenterol Motil. 2008;20:36–42.PubMed
10.
go back to reference Higgins PD, Davis KJ, Laine L. Systematic review: the epidemiology of ischaemic colitis. Aliment Pharmacol Ther. 2004;19:729–738.PubMedCrossRef Higgins PD, Davis KJ, Laine L. Systematic review: the epidemiology of ischaemic colitis. Aliment Pharmacol Ther. 2004;19:729–738.PubMedCrossRef
11.
go back to reference Camilleri M. Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment? Neurogastroenterol Motil. 2007;19:77–84.PubMedCrossRef Camilleri M. Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment? Neurogastroenterol Motil. 2007;19:77–84.PubMedCrossRef
12.
go back to reference Grundy D, Mclean P, Stead R. Impact of 5-HT3 receptor blockade on colonic haemodynamic responses to ischaemia and reperfusion in the rat. Neurogastroenterol Motil. 2007;19:607–616.PubMedCrossRef Grundy D, Mclean P, Stead R. Impact of 5-HT3 receptor blockade on colonic haemodynamic responses to ischaemia and reperfusion in the rat. Neurogastroenterol Motil. 2007;19:607–616.PubMedCrossRef
13.
go back to reference Cole JA, Cook SF, Miller DP, et al. The risk of colonic ischemia among patients with irritable bowel syndrome. Dig Dis Week. 2002; A91 (abstract 726). Cole JA, Cook SF, Miller DP, et al. The risk of colonic ischemia among patients with irritable bowel syndrome. Dig Dis Week. 2002; A91 (abstract 726).
14.
go back to reference MacDonald PH. Ischaemic colitis. Pract Clin Gastroenterol. 2002;16:51–61.CrossRef MacDonald PH. Ischaemic colitis. Pract Clin Gastroenterol. 2002;16:51–61.CrossRef
15.
go back to reference Brandt LJ, Bole SJ. Colonic ischemia. Surg Clin North Am. 1992;72:203–229.PubMed Brandt LJ, Bole SJ. Colonic ischemia. Surg Clin North Am. 1992;72:203–229.PubMed
16.
go back to reference Wolf EL, Sprayregen S, Bakal CW. Radiology in intestinal ischemia: plain film, contrast, and other imaging studies. Surg Clin North Am. 1992;72:107–124.PubMed Wolf EL, Sprayregen S, Bakal CW. Radiology in intestinal ischemia: plain film, contrast, and other imaging studies. Surg Clin North Am. 1992;72:107–124.PubMed
17.
go back to reference Philpotts LE, Heiken JP, Westcott MA, Gore RM. Colitis: use of CT findings in differential diagnosis. Radiology. 1994;190:445–449.PubMed Philpotts LE, Heiken JP, Westcott MA, Gore RM. Colitis: use of CT findings in differential diagnosis. Radiology. 1994;190:445–449.PubMed
18.
go back to reference Iida M, Matsui T, Fuchigami T, et al. Ischemic colitis: serial changes in double–contrast barium enema examination. Radiology. 1986;159:337–341.PubMed Iida M, Matsui T, Fuchigami T, et al. Ischemic colitis: serial changes in double–contrast barium enema examination. Radiology. 1986;159:337–341.PubMed
19.
go back to reference Sreenarasimhaiah J. Diagnosis and management of ischemic colitis. Curr Gastroenterol Rep. 2005;7:421–426.PubMedCrossRef Sreenarasimhaiah J. Diagnosis and management of ischemic colitis. Curr Gastroenterol Rep. 2005;7:421–426.PubMedCrossRef
20.
go back to reference Bryan TG, David AT. Ischemic colitis: a clinical review. South Med J. 2005;98:217–222.CrossRef Bryan TG, David AT. Ischemic colitis: a clinical review. South Med J. 2005;98:217–222.CrossRef
21.
go back to reference Zuckerman GR, Prakash C, Merriman RB, et al. The colon single stripe sign and its relationship to ischemic colitis. Am J Gastroenterol. 2003;98:2018–2022.PubMedCrossRef Zuckerman GR, Prakash C, Merriman RB, et al. The colon single stripe sign and its relationship to ischemic colitis. Am J Gastroenterol. 2003;98:2018–2022.PubMedCrossRef
22.
go back to reference Scoweroft CW, Sanowski RA, Kozarek RA. Colonoscopy in ischemic colitis. Gastrointest Endosc. 1981;27:156–161.CrossRef Scoweroft CW, Sanowski RA, Kozarek RA. Colonoscopy in ischemic colitis. Gastrointest Endosc. 1981;27:156–161.CrossRef
23.
go back to reference Favier C, Bonneau HP, Reboul F. Le diagnostic endoscopique descolites ischémiques régressives. A propos de 21 cas. End Dig. 1976;1:44–148. Favier C, Bonneau HP, Reboul F. Le diagnostic endoscopique descolites ischémiques régressives. A propos de 21 cas. End Dig. 1976;1:44–148.
24.
25.
go back to reference Rosenblum GD, Boyle CM, Schwartz LB. The mesenteric circulation: anatomy and physiology. Surg Clin North Am. 1997;77:289–306.PubMedCrossRef Rosenblum GD, Boyle CM, Schwartz LB. The mesenteric circulation: anatomy and physiology. Surg Clin North Am. 1997;77:289–306.PubMedCrossRef
26.
go back to reference Cappell MS. Intestinal (mesenteric) vasculopathy II. Gastroenterol Clin North Am. 1998;27:827–858.PubMedCrossRef Cappell MS. Intestinal (mesenteric) vasculopathy II. Gastroenterol Clin North Am. 1998;27:827–858.PubMedCrossRef
27.
go back to reference Rogers AI, David S. Intestinal blood flow and diseases of vascular impairment. In: Haubrich WS, Schaffner F, Berk JE, eds. Gastroenterology. 5th ed. Philadelphia: WB Saunders; 1995:1212–1223. Rogers AI, David S. Intestinal blood flow and diseases of vascular impairment. In: Haubrich WS, Schaffner F, Berk JE, eds. Gastroenterology. 5th ed. Philadelphia: WB Saunders; 1995:1212–1223.
28.
go back to reference Mitsudo S, Brandt LJ. Pathology of intestinal ischemia. Surg Clin North Am. 1992;72:43–63.PubMed Mitsudo S, Brandt LJ. Pathology of intestinal ischemia. Surg Clin North Am. 1992;72:43–63.PubMed
29.
go back to reference Scharff JR, Longo WE, Vartanian SM, et al. Ischemic colitis: spectrum of disease and outcome. Surgery. 2003;134:624–630.PubMedCrossRef Scharff JR, Longo WE, Vartanian SM, et al. Ischemic colitis: spectrum of disease and outcome. Surgery. 2003;134:624–630.PubMedCrossRef
30.
go back to reference Dignan CR, Greenson JK. Can ischemic colitis be differentiated from C difficile colitis by biopsy specimens? Am J Surg Pathol. 1997;21:706–710.PubMedCrossRef Dignan CR, Greenson JK. Can ischemic colitis be differentiated from C difficile colitis by biopsy specimens? Am J Surg Pathol. 1997;21:706–710.PubMedCrossRef
Metadata
Title
Endoscopic Findings and Clinicopathologic Characteristics of Ischemic Colitis: A Report of 85 Cases
Authors
Xiaoping Zou
Jun Cao
Yulin Yao
Wenjia Liu
Longdian Chen
Publication date
01-09-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0579-1

Other articles of this Issue 9/2009

Digestive Diseases and Sciences 9/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine